tiprankstipranks
Advertisement
Advertisement
Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
PremiumCompany AnnouncementsGuangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa
2M ago
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
Premium
Company Announcements
Guangzhou Innogen Updates Corporate Articles Following H Share Listing
4M ago
Guangzhou Innogen Pharmaceutical Joins Stock Connect Programs
Premium
Company Announcements
Guangzhou Innogen Pharmaceutical Joins Stock Connect Programs
4M ago
Guangzhou Innogen Invests in Structured Deposit for Treasury Management
PremiumCompany AnnouncementsGuangzhou Innogen Invests in Structured Deposit for Treasury Management
6M ago
Guangzhou Innogen Advances Phase III Trial for Obesity Treatment
Premium
Company Announcements
Guangzhou Innogen Advances Phase III Trial for Obesity Treatment
6M ago
Guangzhou Innogen Launches Diabetes Treatment in Macau
Premium
Company Announcements
Guangzhou Innogen Launches Diabetes Treatment in Macau
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100